Overview

Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the efficacy and safety of single and repeated doses of palonosetron hydrochloride in preventing nausea and vomiting caused by moderate and highly emetogenic chemotherapy in patients.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Changzheng Hospital
Collaborator:
JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd
Treatments:
Emetics
Palonosetron